Abstract
Introduction: Patients with non-small cell lung cancer (NSCLC) are constantly being submitted to re-biopsies for clinical management and investigation of molecular changes in order to determinate the best treatment and monitoring. However, conventional biopsies are highly invasive. The liquid biopsy is a sample of minimally invasive collection, coming from body fluids. This liquid biopsy …